Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.
Alexander D HeiniNaomi A PorretReinhard ZenhaeusernAnnette WinklerVera Ulrike BacherThomas PabstPublished in: Cancers (2021)
We suggest that DTA-CH after ASCT is not associated with an increased risk of relapse or death. The persistence of DTA mutations after induction should not prevent AML patients in CR1 from ASCT consolidation. Independent studies should confirm these data.
Keyphrases
- stem cell transplantation
- acute myeloid leukemia
- end stage renal disease
- high dose
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- emergency department
- peritoneal dialysis
- electronic health record
- low dose
- stem cells
- machine learning
- free survival
- deep learning
- data analysis
- hematopoietic stem cell